Amfani da Magunguna don Asthma Yayin da Ciki

Saboda fuka yana da lafiyar yanayin likita, ba abin mamaki bane cewa kashi 3 zuwa 8 na dukkan ciki yana haifar da ganewar asiri.

Ba kamar wasu sharuɗɗa ba inda za ka iya dakatar da magani a lokacin daukar ciki ko kuma a lokacin farko na ciki lokacin lokacin da ya fi girma ga cututtuka masu illa, asthmatics bukatar daukar magani don kulawa da kyau.

Wannan yana haifar da wasu tambayoyi da suka danganci kare lafiyar magungunan fuka a lokacin daukar ciki, tasiri na ciki a kan tarin fuka dinku, kuma zazzabi zai haifar da haɗari mai haɗari ko haifar da cutar ga jariri ko ku?

Maganar Asthma A lokacin Ciki

Kwayar asthma a cikin ciki za a iya tunaninta ta hanyar mulkin kashi uku-kashi ɗaya bisa uku na masu ciki masu ciki suna samun kwarewa mafi kyau, na uku bai nuna wani canji ba, kuma na karshe na uku ya kara tsanantawa da alamun su. Gaba ɗaya, ƙananan ciwon fuka din kafin ka yi ciki yana da alaka da cutar tarin fuka a yayin daukar ciki.

Yayinda mutum zaiyi tunanin cewa a matsayin gindinku na ciki yana ƙaruwa da ikon ciwon fuka zai kara tsanantawa, amma dai ya zama kamar kishiyar kuma ƙwayar ƙwayar cuta ba ta da tsanani a makonni masu zuwa na ciki. Lokacin da kulawar fuka ya inganta sai ya yi kama da yin haka a hankali a kan hanya mai ciki. A cikin matan da ƙwaƙwalwa suka kara ƙaruwa, yawan tursasawa ya kasance a tsakanin shekarun 29-36 na ciki.

Ƙwararrun cututtukan fuka-fuka sune ba a sani ba a lokacin aiki da bayarwa. Harkokin tarin fuka sun yi kama da karin lokuta na biyu da na uku. A ƙarshe, shirin tarin fuka a yayin daukar ciki yana da maimaita sake maimaita kanta a kan daukar ciki. Idan tarin fuka ya inganta a yayin daukar ciki zai cigaba da inganta tare da ciki a nan gaba kuma a madadin.

Amfanin Asthma a kan Yin ciki

Magungunan fuka mai guba zai iya haifar da dukan matsaloli masu zuwa:

Wadannan rikice-rikice na iya haifar da ƙananan matakan oxygen. Rage yawan matakan oxygen a cikin mahaifa zai iya haifar da rage yawan iskar oxygen don jaririn ku kuma rage yawan jini zuwa ƙirin. Har ila yau, akwai yiwuwar matsalolin magungunan fuka.

Babu wani daga cikin wadannan canje-canje da aka danganta da kula da asma ko kuma sakamakon cutar fuka a kan daukar ciki ya kamata a dauki cewa ma'anar fuka ba za ta yi juna biyu ba. Kyakkyawan kulawa da kulawa zasu rage da rage haɗarin waɗannan rikitarwa.

Mafi yawan ƙwayar fuka dinka, mafi kusantar za ka samu matsalolin fuka.

Tsiraran fuka a ciki

Maganin ƙwayar asibiti a cikin ciki ba duk abin da ya bambanta da maganinka ba a cikin jihar marasa ciki. Kuna buƙatar shirin aikin tarin fuka , buƙatar kulawa da alamun fuka-fuka dinka , da kuma ƙoƙarin kauce wa mawuyacin hali. Ɗaya daga cikin abubuwan da ke kulawa da dan kadan a cikin ciki shine jin dadi na numfashi yawancin marasa lafiya marasa ciki, musamman a baya a ciki.

Gwaji da kuma tayar da hankali, duk da haka, ba al'amuran al'ada ne na ciki ba kuma zai iya kasancewa alamar rashin kulawar asiri. A sakamakon haka, saka idanu da asibiti tare da tsada ko FEV1 na iya zama dan kadan a cikin mai haƙuri. Rage a cikin ko dai daga cikin waɗannan na iya bayar da shawarar ƙwaƙwalwar ƙwaƙwalwa.

Kamar yadda yake tare da mai ciki ba tare da ciki, daina shan taba yana da muhimmanci ga mahaifa mai ciki. Ba wai kawai shan taba yana kara haɗarin ƙwaƙwalwa ba , amma zai iya sa ƙaramin iskar oxygen ya fi muni kuma yana iya ƙara haɗari na fuskantar daya daga cikin matsalolin da aka ambata. Hakazalika, guje wa sauran nau'in ƙura kamar turɓaya, dander , da ƙurar ƙura yana da muhimmiyar ɓangare na shirin aikinku.

Magunguna A lokacin Ciki

Game da cututtukan fuka a ciki, tambayoyin biyu suna da alaka da magunguna.

1. Shin magunguna na asibiti suna da mummunar tasiri a kan jariri mai girma?

2. Shin ciki zai iya canza tasirin magani musamman idan aka kwatanta da tasirinta a cikin rashin ciki?

Magungunan ƙwararru a lokacin daukar ciki sun haɗu da wasu abubuwa masu tsanani masu ban mamaki irin su:

Duk da haka, wanda ya kamata ya san duk wadannan cututtuka masu tasiri sune na kowa a cikin ciki, har ma a cikin mata masu ciki ba tare da asma ba. Alal misali, alamun yanayi na faruwa a cikin kashi 3 cikin dari na haihuwar haihuwa da kuma bata kashi 10-15% na ciki. Ba a yi amfani da magungunan ƙwayoyin ƙwayoyin cuta a halin yanzu a matsayin Aikin A ta Hukumar Kula da Abinci da Drugke ta Amurka. Wadannan sune kwayoyi da ke kula da binciken bincike a cikin mata masu ciki ba su nuna haɗari ga tayin a lokacin da take ciki ba kuma babu wata shaida game da haɗarin haɗari. Yawancin magungunan ƙwayoyin ƙwayoyi sune ko dai B ko kuma aji na C. Wani magani na B na nufin cewa nazarin dabba bai nuna wani haɗari na tayi ba, amma babu wani bincike da aka gudanar a cikin mata masu ciki. Har ila yau, yana nufin cewa akwai wasu hadarin da aka gano a cikin nazarin dabba waɗanda ba a tabbatar da su a baya ba a nazarin mata a farkon farkon shekaru uku kuma ba shaida akan hadarin ba daga baya a ciki. A cikin ƙananan C ba za a iya ƙetare da yin amfani ba sai a la'akari ne kawai idan amfanin da tayi zai iya ƙetare hadarin. A cikin aji na D yana da shaidar tabbatacciyar haɗari, amma yin amfani da miyagun ƙwayoyi zai iya karɓa ba tare da hadarin ba.

Gaba ɗaya, ana jin cewa magani mai mahimmanci don kiyaye kulawar ƙwayar ƙwayar ƙwayar ƙwayar cuta da kuma hana tsangwama ya fi hadarin ƙwayar magungunan da ake amfani dasu akai don maganin fuka. Albuterol, beclomethasone, da budesonide duk sun kasance sunyi amfani da su wajen nazarin magungunan mahaifa da kuma nazarin duk suna da nasaba da sakamakon. A gefe guda, binciken da maganganun da ke cikin magana bai zama kamar ƙarfafa ba. Har ila yau akwai wasu kwayoyi da basu da kwarewa sosai a cikin marasa lafiya marasa ciki.

SABAs . Magoya bayan beta sunyi taimako da sauri don bayyanar cututtukan fuka kamar:

Yayin da SABA na musamman sun nuna alamun dabbobi a cikin dabbobi, babu wani bayanan da ke bayyane yake nuna rayuka a cikin mutane. Nazarin da aka nuna sun nuna 'yan kaɗan idan wasu matsaloli tare da albuterol. Duk da haka, wasu ƙananan karatu sun nuna gastroschisis ko rashin haihuwa wanda aka haifi jariri tare da wasu ko dukkanin hanjinta a waje na ciki saboda wani abu mai mahimmanci a cikin rufin tsoka na ciki. Wata matsala tare da wasu binciken binciken da ke nuna mummunan cutar shine SABA amfani da shi tare da ɓarke-fuka mai rikici wanda zai iya haifar da yawancin matsalolin da aka bayyana a baya.

An yi amfani da masu amfani da beta-bilane-ƙwaƙwalwa a wasu lokuta don hana aikin ba da aiki ba. Maimakon inhaled wadannan kwayoyi an ba ta ta IV. Sakamakon abubuwan da aka fi sani da su na yau da kullum tare da wannan hanyar gwamnati shi ne hyperglycemia ko hawan jini. Lokacin da aka haifa jarirai, wasu lokuta sukan karu da zuciya, razana, da jini masu yalwa saboda sakamakon kula da juna. Dukkanin wadannan cututtuka a cikin jariri suna iya samuwa kuma yawanci, sunyi sauri sosai don haka ba a hana su ba.

LABAs . Kwarewa da LABA da ciki yana da mahimmanci fiye da SABAs. Bisa ga halin da ake ciki a halin yanzu wanda ya haɗa da nazarin mutum da dabba, bai zama kamar salmeterol ko formoterol ya kara yawan hadarin da ke faruwa ba. Akwai ƙarin kwarewar mutum tare da salmeterol. A sakamakon haka, yana da kyau idan mace ta kasance cikin ciki don ci gaba da LABA da ake buƙata don kula da ƙwayar fuka a cikin cikin ciki. Rashin haɓakar rashin lafiyar jiki tare da ɓangaren ƙananan haɗin gwiwa na LABA / inhaled steroid yana kama da matsakaicin matsakaici ko ƙananan ICS monotherapy.

Epinephrine. Saboda haɗarin rage yawan jini zuwa ƙananan cutar, mahalarta mai aiki a kan rashin ciki da Asthma ya bada shawarar cewa wannan magani ne kawai za a yi amfani da su a tsarin anaphylaxis.

Magungunan kwayoyi. Magungunan maganin jijiyoyin da ake amfani da ita suna amfani dashi a cikin ciki don yanayi dabam dabam banda fuka. Wasu damuwa game da amfani da su sun hada da haɗarin matukar damuwa, nakasawar nakasar (mafi yawancin ɓarna), hawan jini, ciki har da ciwon sukari, ƙananan nauyin haifa, da kuma rashin lafiya. Akwai 'yan amsoshi masu mahimmanci. Alal misali, wasu nazarin sun nuna yawan haɗari na ƙwanƙwasawa da sauransu ba su da. Shaidun da ke nuna rashin haihuwa a cikin matan da ke samun situttuka a cikin ciki yana da karfi. A ƙarshe, hawan jini da darajar glucose sune sananne ne don haka, ba mamaki bane. Saboda haka ya zo ne don hadarin gaske. Akwai babbar haɗari ga mahaifi da tayin da suka danganci kulawar asibiti. Rashin haɗari da fuka-fuka mai tsanani ba zai iya nuna rashin lafiyar masu ciwon sukari ga yawancin marasa lafiya ba.

Jirgin steroid. Bayanin lafiyar masu amfani da steroid a lokacin ciki, kamar wancan ga marasa lafiya marasa ciki, yafi ƙarfafawa. Nazarin yin rajistar mai cutar steroid budesonide a cikin matan Sweden bai nuna rashin haɓakawar rashin daidaito ba idan aka kwatanta da yawancin jama'a. Har ila yau, binciken bai nuna matsala ba dangane da ci gaban tayi, mace-mace, ko matsala. Bisa ga waɗannan binciken ne kawai steroid ne kawai ke ɗaukewa da shi a halin yanzu tare da fannin B na. A wani nazari kamar nazarin, fluticasone ya nuna cewa babu wani ƙãra a cikin mawuyacin hali kamar yadda aka kwatanta da sauran steroids. Biyu gwaje-gwajen sarrafawa ba tare da izini ba sun nuna aiki mai kyau da kuma rage yawan karatun.

Leukotriene gyaran. Kamar LABAs, wannan magungunan miyagun ƙwayoyi yana da ƙananan ƙwarewar gwagwarmaya ta zamani, amma bayanai da montelukast ke girma. Bayanan da ba a ba su ba daga wurin rajista na Merck da kuma mai yiwuwa, jarrabawar sarrafawa ya nuna cewa yawancin rashin lafiyar jiki ba su da bambanci daga yawan jama'a. A sakamakon haka, marasa lafiya da ake buƙatar gyare-gyare na leukotriene zai zama mafi alhẽri ta montelukast har sai an sami ƙarin bayanai daga sauran jami'ai.

Anti-immunoglobulin E. Monoclonal anti-immunoglobulin E antibody ko omalizumab an yarda da marasa lafiya tare da ciwon sukari mai raɗaɗi tare da matakan girma na IgE duk da amfani da steroids inhaled. Duk da yake ba a yi la'akari da su ba a cikin binciken binciken asibiti, yawancin rikitarwa irin su ɓarna, haifuwar haihuwa, kananan yara da haihuwa, da kuma rashin lafiyar jiki sun kasance kama da sauran nazarin masu ciki. Babu cikakkun bayanai a yanzu don yin shawarwari don amfani da shi cikin ciki.

Methylxanthines. Akwai kwarewa mai yawa da theophylline da aminophylline a ciki. Duk da yake waɗannan kwayoyi suna lafiya lafiya, asibiti suna canzawa sosai a cikin ciki kuma dole ne a kula da matakai. Ƙarƙashin ƙwararrakin ƙananan yana da ƙananan wanda zai iya magance marasa lafiya marasa ciki. Bugu da ari, kamar yadda a cikin marasa lafiya masu ciki, masu cin zarafi sun fi tasiri ga kula da fuka. A sakamakon haka, wadannan kwayoyi suna da kyau a tunanin su a matsayin masu karawa idan ba a iya samun iko tare da steroid.

Immunotherapy. Duk da yake ba a ba da shawara don fara rigakafi a lokacin daukar ciki ba, wannan ba ya bayyana waɗannan jiyya sun haifar da ƙarin hadari ga mahaifi ko tayin don haka za'a iya cigaba a lokacin daukar ciki.

> Sources

> Tata LJ, Lewis SA, McKeever TM, et al. Sakamakon ƙwaƙwalwar ƙwaƙwalwar ƙwayar cuta, ƙwaƙwalwa da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta a kan ƙananan ɗazuwar haihuwa: nazari na yawan mutanen Birtaniya. Thorax 2008; 63: 981.

> Blais L, Mantawa A. Cikakken ƙwaƙwalwar ƙwaƙwalwa a farkon farkon shekaru uku na ciki da kuma hadarin mummunan yanayin haihuwa tsakanin matan asthmatic. J Allergy Clin Immunol 2008; 121: 1379.

> MPC, MP Schatz M, Kwamitin ACOG kan Dokokin Tsarin Mulki-Obstetrics. Aikin ACOG yayi bulletin: jagororin kulawa na asibiti na masu binciken obstetrician-gynecologists lamba 90, Fabrairu 2008: fuka a ciki. Obstet Gynecol 2008; 111: 457.

> Sauraron S, Mance A, Beauchesne MF, Blais L. Risk na lalacewar nakasar > don > mata masu ciki asthmatic ta yin amfani da β₂-agonist mai tsayi da kuma ciwon hade da corticosteroid da aka hade su zuwa haɗari mai haɗari corticosteroid monotherapy. J Allergy Clin Immunol 2015; 135: 123.

> Namazy JA, Murphy VE, Powell H, et al. Hanyoyin ƙwayar ƙwayar ƙwayar fuka, ƙari da ƙananan corticosteroids a kan sakamakon sakamako. Eur Respir J 2013; 41: 1082.

> MPC Dombrowski, Schatz M, Mai hikima R, et al. Asthma a lokacin daukar ciki. Obstet Gynecol 2004; 103: 5.